Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates

Molecular and Biochemical Parasitology

Volumn 173, Issue 2, 2010, Pages 162-164

  Wyllie, Susan ^a   Mandal, Goutam ^b   Singh, Neeloo ^c   Sundar, Shyam ^d   Fairlamb, Alan H ^a   Chatterjee, Mitali ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antimonial resistance; Leishmania donovani; Tryparedoxin peroxidase

Indexed keywords

ANTIMONY; ANTIOXIDANT; HYDROPEROXIDE; PEROXIDASE; TRYPAREDOXIN PEROXIDASE; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; PEROXIDE; PROTOZOAL PROTEIN; THIOREDOXIN; TRYPAREDOXIN;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; IMMUNOBLOTTING; LEISHMANIA DONOVANI; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PARASITOLOGY; VISCERAL LEISHMANIASIS;

ANTIMONY; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; PEROXIDASES; PEROXIDES; PROTOZOAN PROTEINS; THIOREDOXINS;

LEISHMANIA DONOVANI;

EID: 77954761899     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2010.05.015     Document Type: Article

References (21)

1. Croft S.L., Sundar S., Fairlamb A.H. Drug resistance in Leishmaniasis. Clin Microbiol Rev 2006, 19:111-126.
2. Borst P., Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu Rev Microbiol 1995, 49:427-460.
3. Ouellette M., Légaré D., Papadopoulou B. Multidrug resistance and ABC transporters in parasitic protozoa. J Mol Microbiol Biotechnol 2001, 3:201-206.
4. Mukherjee A., Padmanabhan P.K., Singh S., et al. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 2007, 59:204-211.
5. Mittal M.K., Rai S., Ravinder A., Gupta S., Sundar S., Goyal N. Characterization of natural antimony resistance in Leishmania donovani isolates. Am J Trop Med Hyg 2007, 76:681-688.
6. Mandal G., Wyllie S., Singh N., Sundar S., Fairlamb A.H., Chatterjee M. Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 2007, 134:1679-1687.
7. Fairlamb A.H., Cerami A. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 1992, 46:695-729.
8. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellette M. Co-amplification of the g-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 1997, 16:3057-3065.
9. Haimeur A., Guimond C., Pilote S., et al. Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol 1993, 34:726-735.
10. Légaré D., Richard D., Mukhopadhyay R., et al. The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 2001, 276:26301-26307.
11. Wyllie S., Cunningham M.L., Fairlamb A.H. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 2004, 279:39925-39932.
12. Flohé L., Hecht H.J., Steinert P. Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 1999, 27:966-984.
13. Flohe L., Budde H., Hofmann B. Peroxiredoxins in antioxidant defense and redox regulation. BioFactors 2003, 19:3-10.
14. Flohé L., Budde H., Bruns K., et al. Tryparedoxin peroxidase of Leishmania donovani: Molecular cloning, heterologous expression, specificity, and catalytic mechanism. Arch Biochem Biophys 2002, 397:324-335.
15. Levick M.P., Tetaud E., Fairlamb A.H., Blackwell J.M. Identification and characterisation of a functional peroxidoxin from Leishmania major. Mol Biochem Parasitol 1998, 96:125-137.
16. Lin Y.C., Hsu J.Y., Chiang S.C., Lee S.T. Distinct overexpression of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential detoxification of different oxidants in arsenite-resistant Leishmania amazonensis with and without DNA amplification. Mol Biochem Parasitol 2005, 142:66-75.
17. Wyllie S., Vickers T.J., Fairlamb A.H. Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials. Antimicrob Agents Chemother 2008, 52:1359-1365.
18. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 2002, 6:849-854.
19. Mandal G., Sarkar A., Saha P., Singh N., Sundar S., Chatterjee M. Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates. Indian J Biochem Biophys 2009, 46:86-92.
20. Cunningham M.L., Fairlamb A.H. Trypanothione reductase from Leishmania donovani-purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem 1995, 230:460-468.
21. Mandal S., Maharjan M., Singh S., Chatterjee M., Madhubala R. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 2010, 65:496-507.